海产智讯

St. Olavs Hospital study in Norway: 61 patients examined for salmon asthma, most leave the salmon industry because of too few non-exposed positions

The salmon asthma outpatient study at St. Olavs Hospital in Norway, underway since 2019, has registered 61 patients examined, about 9 per year. Study lead Carl Fredrik Fagernæs said the vast majority of diagnosed patients ultimately leave the salmon industry because there are too few non-exposed positions within companies.

Carl Fredrik Fagernæs, a specialist in occupational medicine and PhD at St. Olavs Hospital in Norway, said in a written interview with Norwegian aquaculture news outlet iLaks on 17 November 2026 that the hospital's salmon asthma outpatient study, launched in 2019, has so far registered 61 patients examined for salmon asthma, averaging about 9 per year.

Fagernæs said salmon is now the most common cause of occupational asthma at the hospital's outpatient clinic. Based on a rough estimate from the hospital's examination records from 2012 to 2017, about one in five patients examined for work-related asthma at the outpatient clinic worked in the salmon industry.

"Salmon asthma" is a term for a form of occupational asthma, referring to occupational asthma most likely caused by work in the salmon industry. Fagernæs said occupational asthma is a problem in many occupations, including bakers, farmers, car painters and hairdressers, and patients from these occupations have appeared at the Trondheim clinic for many years; what is new is the increase in patients from the salmon industry over the past roughly 15 to 20 years. Because the salmon industry is relatively poorly documented in the literature compared with other forms of occupational asthma (such as baker's asthma and isocyanate asthma), St. Olavs Hospital decided to establish a research registry for salmon asthma patients.

iLaks last reported on the study in 2024, when 36 patients had been examined for salmon asthma, of whom 21 received a diagnosis of "occupational asthma." Fagernæs said this time that the number of people diagnosed with occupational asthma has not been counted since February 2024, but the overall impression is that the number of diagnosed cases has also remained stable, with data stable since the study began.

On where patients go, Fagernæs cited results published in 2024 showing that most patients were either on sick leave or had already quit their jobs; a few were reassigned within the company to non-exposed positions, and even fewer remained in the same exposed environment. The impression since 2024 is the same: the vast majority leave the salmon industry because there are too few non-exposed positions within companies. He noted that among the patients seen at the clinic, few received arrangements allowing them to work outside the exposure areas, for example cleaning offices or working in canteens.

Fagernæs said patients found to have occupational asthma caused by salmon are advised not to work in production areas, to avoid contact with fine particles produced by salmon, which carries the risk of worsening illness and chronic asthma.

The salmon asthma phenomenon is also part of the SHInE study, led by researchers at the University Hospital of North Norway (Universitetssykehuset Nord-Norge) in Tromsø. Fagernæs said that in 2025 they published an article together with researchers in Tromsø and Bergen showing that one in five people working in gutting or filleting in the production areas of salmon slaughterhouses reported work-related asthma symptoms. The result was based on cross-sectional data from 867 workers at 9 processing plants along the Norwegian coast. Fagernæs stressed that work-related asthma symptoms do not necessarily mean the person actually has asthma.

Fagernæs said most participants in the outpatient study are young, in good health and willing to keep working. He thanked the many patients who agreed to take part in the research project, and noted that several employers in the salmon industry have a positive attitude toward the research, with some expressing interest in continuing to build knowledge and take part in new projects. He also said the interdisciplinary cooperation with the professional environments in occupational medicine in Tromsø and Bergen during the study has been very beneficial.

The outpatient study is planned to run until 2029 and to include up to 100 patients. Partners include the Department of Occupational and Environmental Medicine at the University Hospital of North Norway (UNN) and the Department of Occupational Medicine at Haukeland University Hospital (Haukeland universitetssjukehus) in Bergen.

Comments(0)

No comments yet. Be the first to comment.

Leave a comment

Comments are reviewed before publication; anything that is not approved stays private.